<p>WuXi Biologics (Cayman) Inc. has entered into a strategic collaboration with Sinorda Biomedicine to accelerate the development and manufacturing of SND006, a novel bispecific antibody targeting inflammatory bowel disease and other autoimmune diseases. Under the partnership, Sinorda Biomedicine will utilize WuXi Biologics’ expertise and manufacturing capabilities to advance SND006 through preclinical pharmacology studies and clinical supply, expediting the Investigational New Drug (IND) application process in both China and the United States. The collaboration aims to address unmet medical needs in autoimmune diseases and may expand to include additional projects from Sinorda Biomedicine’s pipeline. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Wuxi Biologics (Cayman) Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: CN73982) on January 29, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)</p>

<p>WuXi Biologics has partnered with Sinorda Biomedicine to develop SND006, a bispecific antibody for autoimmune diseases. The collaboration will leverage WuXi's manufacturing expertise to expedite preclinical studies and the IND application process in China and the U.S. This partnership aims to address unmet medical needs in autoimmune diseases and may extend to other projects in Sinorda's pipeline.</p>

Reuters

iShares US Pharma

Tianhong CNI BIOMEDICINE ETF

Ark Genomic Revolution ETF

ALPS Medical Breakthrough

Founder Fubon CSI Medicine and Medical Device Innovation ETF

Bosera Hang Seng Health Care ETF(QDII)

ChinaAMC SSE STAR Biology and Medicine ETF

Invesco Nasdaq Biotechnology ETF

Yinhua CSI Innovative Drugs Industry ETF

Huaan Hang Seng Biotech ETF

China Merchants CSI Biotechnology Theme ETF

VanEck Biotech ETF

E Fund CSI Biotechnology Theme ETF

Penghua SSE STAR Biology and Medicine ETF

Ping An CSI Medicine and Medical Device Innovation ETF

Health Care Select Sector SPDR

Invesco Biotechnology & Genome ETF

VG Health

Guotai CSI Bio-medicine ETF

Minsheng Royal CSI Biotechnology Theme ETF

Proshares Ultra Nasdaq Biotech

First Trust NYSE Arca Biotech Index Fd

WUXI BIO

WuXi Biologics

ChinaAMC SSE Health Care ETF Initiating Fund

iShares Global Healthcare

ChinaAMC CSI Biotechnology Theme ETF

SPDR S&P Biotech

iShares Biotechnology ETF

WuXi Biologics and Sinorda Biomedicine Partner to Advance Bispecific Antibody for Autoimmune Diseases